CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
Laurus Labs receives EIR from USFDA for API facilities
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
Partnership to facilitate collaborative research in academia and industry to further progress in life sciences
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Subscribe To Our Newsletter & Stay Updated
